Cassava Sciences Inc (SAVA)
27.08
+0.12
(+0.45%)
USD |
NASDAQ |
Oct 04, 16:00
27.07
-0.01
(-0.04%)
After-Hours: 20:00
Cassava Sciences Shareholders Equity (Annual): 137.47M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 137.47M |
| December 31, 2022 | 227.54M |
| December 31, 2021 | 253.92M |
| December 31, 2020 | 92.20M |
| December 31, 2019 | 22.10M |
| December 31, 2018 | 19.63M |
| December 31, 2017 | 9.699M |
| December 31, 2016 | 18.64M |
| December 31, 2015 | 29.37M |
| December 31, 2014 | 40.06M |
| December 31, 2013 | 48.30M |
| December 31, 2012 | 13.14M |
| December 31, 2011 | 44.39M |
| Date | Value |
|---|---|
| December 31, 2010 | 32.93M |
| December 31, 2009 | 108.25M |
| December 31, 2008 | 104.29M |
| December 31, 2007 | 103.91M |
| December 31, 2006 | 77.92M |
| December 31, 2005 | 63.36M |
| December 31, 2004 | 93.40M |
| December 31, 2003 | 76.56M |
| December 31, 2002 | 50.22M |
| December 31, 2001 | 65.62M |
| December 31, 2000 | 78.69M |
| December 31, 1999 | 9.141M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
22.10M
Minimum
2019
253.92M
Maximum
2021
146.64M
Average
137.47M
Median
2023
Shareholders Equity (Annual) Benchmarks
| Bristol-Myers Squibb Co | 29.43B |
| Eli Lilly and Co | 10.77B |
| Seelos Therapeutics Inc | -33.51M |
| Biomarin Pharmaceutical Inc | 4.952B |
| EyePoint Pharmaceuticals Inc | 266.32M |